Literature DB >> 14654779

Identification of novel ERK-mediated feedback phosphorylation sites at the C-terminus of B-Raf.

Tilman Brummer1, Heike Naegele, Michael Reth, Yukiko Misawa.   

Abstract

The extracellular signal-regulated kinase (ERK) pathway plays an important role during the development and activation of B lymphocytes. We have recently shown that B-Raf is a dominant ERK activator in B-cell antigen receptor signalling. We now show that B-Raf is hyperphosphorylated upon BCR engagement and undergoes a prominent electrophoretic mobility shift. This shift correlates with ERK activation and is prevented by the MEK inhibitor U0126. Syk-deficient DT40 B cells display neither dual ERK phosphorylation nor a mobility shift of B-Raf upon BCR engagement. The inducible expression of a constitutively active B-Raf in this mutant line restores dual ERK phosphorylation and the mobility shift of endogenous B-Raf, indicating that these two events are connected to each other. By site-directed mutagenesis studies, we demonstrate that the shift is due to an ERK2-mediated feedback phosphorylation of serine/threonine residues within an evolutionary conserved SPKTP motif at the C-terminus of B-Raf. Replacement of these residues by negatively charged amino acids causes a constitutive mobility shift and a reduction of PC12 cell differentiation. We discuss a model in which ERK-mediated phosphorylation of the SPKTP motif is involved in negative feedback regulation of B-Raf.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14654779     DOI: 10.1038/sj.onc.1207185

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  50 in total

1.  Phosphorylation of c-Cbl and p85 PI3K driven by all-trans retinoic acid and CD38 depends on Lyn kinase activity.

Authors:  Johanna Congleton; Miaoqing Shen; Robert MacDonald; Fabio Malavasi; Andrew Yen
Journal:  Cell Signal       Date:  2014-03-29       Impact factor: 4.315

Review 2.  Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells.

Authors:  James A McCubrey; Stephen L Abrams; Kristin Stadelman; William H Chappell; Michelle Lahair; Richard A Ferland; Linda S Steelman
Journal:  Adv Enzyme Regul       Date:  2009-11-04

3.  Wallenda/DLK protein levels are temporally downregulated by Tramtrack69 to allow R7 growth cones to become stationary boutons.

Authors:  Alexander I Feoktistov; Tory G Herman
Journal:  Development       Date:  2016-07-11       Impact factor: 6.868

Review 4.  The clinical development of MEK inhibitors.

Authors:  Yujie Zhao; Alex A Adjei
Journal:  Nat Rev Clin Oncol       Date:  2014-05-20       Impact factor: 66.675

Review 5.  JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships.

Authors:  András Zeke; Mariya Misheva; Attila Reményi; Marie A Bogoyevitch
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-27       Impact factor: 11.056

6.  Discrete cytosolic macromolecular BRAF complexes exhibit distinct activities and composition.

Authors:  Britta Diedrich; Kristoffer Tg Rigbolt; Michael Röring; Ricarda Herr; Stephanie Kaeser-Pebernard; Christine Gretzmeier; Robert F Murphy; Tilman Brummer; Jörn Dengjel
Journal:  EMBO J       Date:  2017-01-16       Impact factor: 11.598

Review 7.  Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.

Authors:  Scott T Eblen
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

8.  A Mek1-Mek2 heterodimer determines the strength and duration of the Erk signal.

Authors:  Federica Catalanotti; Gloria Reyes; Veronika Jesenberger; Gergana Galabova-Kovacs; Ricardo de Matos Simoes; Oliviero Carugo; Manuela Baccarini
Journal:  Nat Struct Mol Biol       Date:  2009-02-15       Impact factor: 15.369

9.  Cellular Ser/Thr-kinase assays using generic peptide substrates.

Authors:  Deanna G Adams; Yu Wang; Puiying A Mak; Jason Chyba; Orzala Shalizi; Jason Matzen; Paul Anderson; Tim R Smith; Michael Garcia; Genevieve L Welch; Emmanuel J Claret; Michel Fink; Anthony P Orth; Jeremy S Caldwell; Achim Brinker
Journal:  Curr Chem Genomics       Date:  2008-05-23

10.  Expression of excess receptors and negative feedback control of signal pathways are required for rapid activation and prompt cessation of signal transduction.

Authors:  Hiroshi Kobayashi; Ryuzo Azuma; Takuo Yasunaga
Journal:  Cell Commun Signal       Date:  2009-03-03       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.